Literature DB >> 11914297

Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses.

Toshiaki A Furukawa1, Gordon H Guyatt, Lauren E Griffith.   

Abstract

BACKGROUND: Meta-analyses summarize the magnitude of treatment effect using a number of measures of association, including the odds ratio (OR), risk ratio (RR), risk difference (RD) and/or number needed to treat (NNT). In applying the results of a meta-analysis to individual patients, some textbooks of evidence-based medicine advocate individualizing NNT, based on the RR and the patient's expected event rate (PEER). This approach assumes constant RR but no empirical study to date has examined the validity of this assumption.
METHODS: We randomly selected a subset of meta-analyses from a recent issue of the Cochrane Library (1998, Issue 3). When a meta-analysis pooled more than three randomized controlled trials (RCT) to produce a summary measure for an outcome, we compared the OR, RR and RD of each RCT with the corresponding pooled OR, RR and RD from the meta-analysis of all the other RCT. Using the conventional P-value of 0.05, we calculated the percentage of comparisons in which there were no statistically significant differences in the estimates of OR, RR or RD, and refer to this percentage as the 'concordance rate'.
RESULTS: For each effect measure, we made 1843 comparisons, extracted from 55 meta-analyses. The random effects model OR had the highest concordance rate, closely followed by the fixed effects model OR and random effects model RR. The minimum concordance rate for these indices was 82%, even when the baseline risk differed substantially. The concordance rates for RD, either fixed effects or random effects model, were substantially lower (54-65%).
CONCLUSIONS: The fixed effects OR, random effects OR and random effects RR appear to be reasonably constant across different baseline risks. Given the interpretational and arithmetic ease of RR, clinicians may wish to rely on the random effects model RR and use the PEER to individualize NNT when they apply the results of a meta-analysis in their practice.

Entities:  

Mesh:

Year:  2002        PMID: 11914297     DOI: 10.1093/ije/31.1.72

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  76 in total

Review 1.  Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review.

Authors:  Toshi A Furukawa; Hugh McGuire; Corrado Barbui
Journal:  BMJ       Date:  2002-11-02

Review 2.  Mirtazapine versus other antidepressive agents for depression.

Authors:  Norio Watanabe; Ichiro M Omori; Atsuo Nakagawa; Andrea Cipriani; Corrado Barbui; Rachel Churchill; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 3.  Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat.

Authors:  Alexandra Barratt; Peter C Wyer; Rose Hatala; Thomas McGinn; Antonio L Dans; Sheri Keitz; Virginia Moyer; Gordon Guyatt For
Journal:  CMAJ       Date:  2004-08-17       Impact factor: 8.262

Review 4.  Frequency of treatment-effect modification affecting indirect comparisons: a systematic review.

Authors:  Michael Coory; Susan Jordan
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  Consistently estimating absolute risk difference when translating evidence to jurisdictions of interest.

Authors:  Simon Eckermann; Michael Coory; Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2011-02       Impact factor: 4.981

6.  Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Susan L Norris; Sam Schulman; Jack Hirsh; Mark H Eckman; Elie A Akl; Mark Crowther; Per Olav Vandvik; John W Eikelboom; Marian S McDonagh; Sandra Zelman Lewis; David D Gutterman; Deborah J Cook; Holger J Schünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 7.  Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.

Authors:  T A Furukawa; N Watanabe; R Churchill
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 8.  Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.

Authors:  David M Kent; Ewout Steyerberg; David van Klaveren
Journal:  BMJ       Date:  2018-12-10

9.  How to work with a subgroup analysis.

Authors:  Bernadette Dijkman; Bauke Kooistra; Mohit Bhandari
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

Review 10.  Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies.

Authors:  Corrado Barbui; Eleonora Esposito; Andrea Cipriani
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.